Nokia is pouring roughly $30 million into its Allentown, Pennsylvania, facility to scale up semiconductor testing and packaging. The investment aims to boost production capacity tenfold by the third quarter, positioning the site to meet the exploding demand for the optical networking hardware that underpins artificial intelligence infrastructure.
Furniture manufacturer Natuzzi is launching a comprehensive financial and operational overhaul to survive the most turbulent market cycle in decades. Facing a sharp decline in consumer demand and geopolitical volatility, the Italian firm is moving to shrink its footprint and shed non-core assets to stave off further fiscal erosion.
Senators Ed Markey and Richard Blumenthal are pushing the National Highway Traffic Safety Administration to investigate Tesla’s Full Self-Driving safety data. The lawmakers argue that the company’s assertion that its vehicles are ten times safer than human drivers relies on flawed methodology designed to inflate performance statistics.
Senators Ed Markey and Richard Blumenthal are pushing federal regulators to launch a rigorous investigation into Tesla’s Full Self-Driving technology. The lawmakers argue that the company’s internal safety statistics rely on flawed methodologies that artificially inflate the performance of its autonomous systems compared to human drivers.
A federal appeals court has delivered a decisive blow to Bacardi Ltd.’s long-standing campaign to seize the Havana Club trademark. The Fourth Circuit panel ruled that the U.S. Patent and Trademark Office acted within its authority when it permitted the Cuban state-owned entity, Cubaexport, to renew the registration.
Amkor Technology shares surged 6.7% to $91.19 in midday trading Tuesday, riding a wave of investor confidence following a decade-long partnership agreement with Taiwan Semiconductor Manufacturing Co. The deal promises to anchor a more robust domestic semiconductor supply chain, marking a significant milestone for the Arizona-based provider.
The Food and Drug Administration has granted approval to Amphastar Pharmaceuticals for Rextovy, a non-prescription nasal spray designed to reverse opioid overdoses. By authorizing direct consumer access at pharmacies and convenience stores, the agency aims to broaden the availability of life-saving interventions while fostering market competition to lower costs.
Snap is betting that the era of the smartphone is waning, debuting a pair of augmented reality glasses priced at $2,195. The company intends to shift computing away from pocket-sized screens and into the physical world, positioning its new SPECS hardware as an essential tool for navigation and contextual AI assistance.
A sharp 22% drop in New York and 20% decline in Toronto hit Gildan Activewear on Tuesday, marking the company’s worst single-day performance since 2019. The sudden selloff followed a critical report from Jehoshaphat Research that challenged the apparel manufacturer’s financial reporting accuracy and inventory management practices.
Crude oil benchmarks tumbled roughly $5 per barrel midday Tuesday following reports that the U.S. will permit Iran to resume immediate oil and fuel exports. The move, tied to a looming deal to conclude ongoing hostilities, includes vital exemptions for banking, transportation, and insurance services required to facilitate global trade.
A 36% cratering of Domo’s share price followed the software firm’s admission that it lacks the necessary capital to sustain operations over the coming year. Trading at $2.07 by midday Tuesday, the company’s valuation has now plummeted 76% since January, signaling a severe erosion of investor confidence.
A group of lenders has finalized the acquisition of FAT Brands for $595 million, effectively seizing control of 1,700 restaurant locations worldwide. The deal marks the culmination of a contentious bankruptcy process that recently stripped founder Andrew Wiederhorn of his leadership role and ousted his family members from the company’s operations.
Canada’s antitrust watchdog has opened a formal investigation into the country’s food-supply chain, scrutinizing everything from production and transportation to retail pricing. The move follows Prime Minister Mark Carney’s recent critique of a market landscape dominated by five major grocers that stifle competition and inflate costs for independent retailers.
A 17% drop in Groupe Dynamite shares on Tuesday signaled investor concern after the fast-fashion retailer missed quarterly revenue and same-store sales targets. While the company continues to expand its footprint across North America and the U.K., the figures suggest the rapid growth pace seen in recent months is moderating.
A 13% surge in NeOnc Technologies stock followed news that Abu Dhabi health officials have greenlit Phase 2 clinical trials for the company’s experimental brain cancer drug. The $5.09 share price reflects investor optimism as the firm expands its testing footprint beyond ongoing U.S. regulatory discussions.
Persistent refinery demand and robust export activity are driving U.S. crude oil stockpiles lower for the eighth consecutive week. Analysts surveyed by The Wall Street Journal project a commercial inventory draw of 3.5 million barrels for the week ending June 12, as the energy sector sustains high operational throughput.
A fresh $8.4 million contract to supply high-performance servers for a U.S. Department of Defense intelligence platform sent One Stop Systems shares climbing 6% in premarket trading. The deal marks a significant expansion for the firm, pushing its valuation to $18.30 as investors react to the new government-backed project.
Shareholders of Simulations Plus are set to receive $18.50 per share in an all-cash buyout by affiliates of Altaris, a deal valuing the drug development software firm at approximately $375 million. The acquisition, confirmed Tuesday, aims to merge the company into Altaris’ existing portfolio brand, Chemical Computing Group.
Salesforce is injecting $1 billion into the Italian market over the next five years, a strategic move aimed at scaling its local footprint. The enterprise software giant intends to anchor this growth by establishing a new hub in Milan and aggressively recruiting top-tier talent in artificial intelligence and data science.
As inflation continues to tighten household budgets across Canada, Dollarama is betting on a new multi-year partnership with Bank of Montreal to keep shoppers returning. Starting this week, customers using the BMO Blue Rewards loyalty program can earn points on transactions exceeding 20 Canadian dollars at any of the retailer's 1,700 locations.
A 78% premium over the 90-day volume-weighted average price has secured a deal for Open Lending, as ANV Group moves to acquire the automotive finance partner for $383.4 million. The all-cash transaction marks the end of Open Lending’s tenure on the Nasdaq, shifting the company into private ownership by the third quarter.
A letter of intent signed with the Department of Commerce earmarks up to $50 million in CHIPS and Science Act funding for Coherent, fueling a major expansion of its Sherman, Texas, semiconductor facility to meet the surging demand for high-performance optical networking components required by modern artificial intelligence data centers.
A 5.5% monthly jump in existing-home sales during May signals a potential turning point for Canada’s long-stalled real estate market. The increase, the most significant since October 2024, arrives after an extended period of declining demand, persistent price drops, and economic headwinds that have squeezed the sector for over a year.
Canada's largest telecommunications provider is eliminating approximately 690 positions, representing 1% of its total workforce. The move arrives as the company struggles against a cooling subscriber market and aggressive national wireless competition, forcing a shift in strategy to protect margins in a tightening economic climate.
Shares of Outlook Therapeutics surged 20% on Tuesday, hitting $1.39, after federal regulators accepted the company’s resubmitted application for ONS-5010, a treatment for wet age-related macular degeneration. This latest regulatory milestone follows a month-long rally that has seen the company’s stock value quadruple.
Sanuwave Health shares plummeted 37% to $9.22 in early trading after the medical device manufacturer slashed its second-quarter revenue outlook. The company now expects between $8.5 million and $9.5 million in revenue, a significant retreat from the $11.1 million to $11.6 million projection issued just last month.
The European Central Bank could push borrowing costs higher even as markets react to a potential U.S.-Iran peace deal. Chief Economist Philip Lane signaled Tuesday that while energy price volatility has eased, the inflation outlook remains precarious enough to justify further tightening if incoming data demands it.
Faced with a July 4 deadline and the threat of 25% tariffs on car imports, European lawmakers voted 440 to 151 on Tuesday to approve a contentious trade deal with the United States. The decision follows a volatile period of negotiations initiated at President Trump’s Turnberry golf course last summer.
Stepping beyond its identity as a Covid-19 vaccine manufacturer, Moderna is initiating a broad organizational restructuring to support an ambitious portfolio of upcoming product launches. The biotechnology company is consolidating its operational oversight under President Stephen Hoge while installing a new chief commercial officer to lead global market penetration.
A $1.48 per share offer from Forward Industries failed to gain traction this week, as the board of digital-asset holder Solana unanimously rebuffed the unsolicited takeover attempt. Directors characterized the all-stock proposal as a significant undervaluation of the company, effectively shutting down the acquisition bid without further negotiation.
